Literature DB >> 24388677

Alpha-amylase and alpha-glucosidase inhibition is differentially modulated by fucoidan obtained from Fucus vesiculosus and Ascophyllum nodosum.

Kyung-Tae Kim1, Laurie-Eve Rioux1, Sylvie L Turgeon2.   

Abstract

Fucoidan is a water-soluble, negatively charged, biologically active polysaccharide found in great abundance in brown marine algae. However, the inhibition of α-amylase and α-glucosidase by fucoidan derived from two algal species (Ascophyllum nodosum and Fucus vesiculosus) harvested at different periods (accounting for seasonal and yearly variations) has never been investigated. It was found that fucoidans inhibited α-glucosidase differently, depending on the algal species from which it was extracted and the algae's season of harvest. Fucoidan extracted from A. nodosum was a more potent inhibitor of α-glucosidase, with an IC50 ranging from 0.013 to 0.047 mg/mL, than the inhibition by fucoidan extracted from F. vesiculosus (IC50=0.049 mg/mL). In contrast, fucoidan extracted from F. vesiculosus did not inhibit α-amylase activity, while fucoidan from A. nodosum decreased α-amylase activity by 7-100% at 5 mg/mL depending upon the algae harvest period. An IC50 of 0.12-4.64 mg/mL for fucoidan from A. nodosum was found for the α-amylase inhibition. The ability of fucoidan to inhibit α-amylase and α-glucosidase thus varies according to the algae species and harvest period. A. nodosum is more suitable than F. vesiculosus as a source of fucoidan to inhibit α-amylase and α-glucosidase activities. Their potential benefits towards Type 2 diabetes management should be further investigated.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ascophyllum nodosum; Brown seaweed; Enzyme inhibition; Fucoidan; Fucus vesiculosus; Harvest season; Sulfated fucan; Type 2 diabetes; α-Amylase; α-Glucosidase

Mesh:

Substances:

Year:  2013        PMID: 24388677     DOI: 10.1016/j.phytochem.2013.12.003

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  36 in total

1.  Antioxidant and antidiabetic properties of tartary buckwheat rice flavonoids after in vitro digestion.

Authors:  Tao Bao; Ye Wang; Yu-Ting Li; Vemana Gowd; Xin-He Niu; Hai-Ying Yang; Li-Shui Chen; Wei Chen; Chong-de Sun
Journal:  J Zhejiang Univ Sci B       Date:  2016 Dec.       Impact factor: 3.066

2.  Enzymatic hydrolysis of perilla seed meal yields water-soluble dietary fiber as a potential functional carbohydrate source.

Authors:  Yeo Jin Hwang; Kyung Young Yoon
Journal:  Food Sci Biotechnol       Date:  2020-03-03       Impact factor: 2.391

3.  Low molecular weight fucoidan ameliorates diabetic nephropathy via inhibiting epithelial-mesenchymal transition and fibrotic processes.

Authors:  Jihui Chen; Wentong Cui; Quanbin Zhang; Yingli Jia; Yi Sun; Lin Weng; Dali Luo; Hong Zhou; Baoxue Yang
Journal:  Am J Transl Res       Date:  2015-09-15       Impact factor: 4.060

4.  The assessment of antidiabetic properties of novel synthetic curcumin analogues: α-amylase and α-glucosidase as the target enzymes.

Authors:  Fatemeh Hasaninezhad; Zohreh Tavaf; Farhad Panahi; Maryam Nourisefat; Ali Khalafi-Nezhad; Reza Yousefi
Journal:  J Diabetes Metab Disord       Date:  2020-11-12

5.  Phlorotannins from Alaskan seaweed inhibit carbolytic enzyme activity.

Authors:  Joshua Kellogg; Mary H Grace; Mary Ann Lila
Journal:  Mar Drugs       Date:  2014-10-22       Impact factor: 5.118

6.  Alleviating effects of lupeol on postprandial hyperglycemia in diabetic mice.

Authors:  Hyun-Ah Lee; Min-Jung Kim; Ji-Sook Han
Journal:  Toxicol Res (Camb)       Date:  2021-05-08       Impact factor: 3.524

Review 7.  Potential Bioactive Compounds from Seaweed for Diabetes Management.

Authors:  Yusrizam Sharifuddin; Yao-Xian Chin; Phaik-Eem Lim; Siew-Moi Phang
Journal:  Mar Drugs       Date:  2015-08-21       Impact factor: 5.118

8.  Extraction Optimization, Preliminary Characterization and Bioactivities in Vitro of Ligularia hodgsonii Polysaccharides.

Authors:  Xueping Song; Jun Tang
Journal:  Int J Mol Sci       Date:  2016-05-21       Impact factor: 5.923

Review 9.  Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A Hypothesis.

Authors:  Alexa Klettner
Journal:  Mar Drugs       Date:  2016-02-03       Impact factor: 5.118

10.  In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.).

Authors:  Sundar Poovitha; Madasamy Parani
Journal:  BMC Complement Altern Med       Date:  2016-07-18       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.